Enanta Pharmaceuticals In... (ENTA)
NASDAQ: ENTA
· Real-Time Price · USD
8.00
0.26 (3.36%)
At close: Aug 15, 2025, 3:59 PM
8.00
0.00%
After-hours: Aug 15, 2025, 04:01 PM EDT
Enanta Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 18.31M | 14.93M | 16.96M | 14.61M | 17.97M | 17.05M | 18M | 18.93M | 18.89M | 17.8M | 23.59M | 20.32M | 19.48M | 18.72M | 27.65M | 23.57M | 21.62M | 20.13M | 31.74M |
Cost of Revenue | n/a | 1.2M | 889K | 479K | 594K | 621K | 642K | 669K | n/a | 540K | 511K | 655K | 716K | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -31.89M | 14.93M | 16.96M | 14.61M | 17.97M | 17.05M | 18M | 18.93M | 18.89M | 17.25M | 23.07M | 19.66M | 18.76M | 18.72M | 27.65M | 23.57M | 21.62M | 20.13M | 31.74M |
Operating Income | -18.89M | -24.53M | -23.54M | -29.85M | -24.18M | -32.77M | -34.89M | -31.03M | -36.71M | -39.45M | -30.01M | -27.05M | -32.54M | -33.85M | -30.41M | -33.73M | -33.85M | -29.7M | -12.3M |
Interest Income | 2.29M | 2.29M | 2.8M | 3.18M | 3.49M | 3.81M | 4.3M | 4.66M | 3.87M | 1.84M | 993K | n/a | 393K | 255K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -18.23M | -23.95M | -22.71M | -29.19M | -23.05M | -31.52M | -34.03M | -29.52M | -34.84M | -37.61M | -29.02M | -26.33M | -32.15M | -33.59M | -30.15M | -33.39M | -33.41M | -29.16M | -11.62M |
Net Income | -18.25M | -22.64M | -22.29M | -28.82M | -22.66M | -31.16M | -33.41M | -28.11M | -39.06M | -37.66M | -28.99M | -26.35M | -31.7M | -33.34M | -30.11M | -24.6M | -24.02M | -22.05M | -8.33M |
Selling & General & Admin | 10M | 11.39M | 12.85M | 13.68M | 13.41M | 14.23M | 16.52M | 13.79M | 12.62M | 13.78M | 12.7M | 12.57M | 12.93M | 10.48M | 9.51M | 8.36M | 8.48M | 8.33M | 7.38M |
Research & Development | 27.21M | 28.07M | 27.66M | 30.78M | 28.74M | 35.59M | 36.37M | 36.17M | 42.99M | 43.47M | 40.9M | 34.8M | 39.09M | 42.09M | 48.55M | 48.95M | 46.99M | 41.51M | 36.66M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 393K | 255K | 258K | 333K | 439K | n/a | n/a |
Operating Expenses | 37.21M | 39.45M | 40.5M | 44.46M | 42.16M | 49.82M | 52.89M | 49.96M | 55.6M | 57.25M | 53.6M | 47.37M | 52.02M | 52.56M | 58.06M | 57.3M | 55.47M | 49.83M | 44.04M |
Interest Expense | 1.62M | 1.71M | 1.96M | 2.58M | 2.35M | 2.56M | 3.44M | 3.15M | 2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 545K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 37.21M | 39.45M | 40.5M | 44.46M | 42.16M | 49.82M | 52.89M | 49.96M | 55.6M | 57.25M | 53.6M | 47.37M | 52.02M | 52.56M | 58.06M | 57.3M | 55.47M | 49.83M | 44.04M |
Income Tax Expense | 29K | -1.3M | -416K | -363K | -395K | -363K | -622K | -1.41M | 4.22M | 44K | -34K | 14K | -447K | -255K | -36K | -8.79M | -9.38M | -7.11M | -3.29M |
Shares Outstanding (Basic) | 21.32M | 21.36M | 21.24M | 21.19M | 21.18M | 21.17M | 21.09M | 21.06M | 21.05M | 21.04M | 20.82M | 20.6M | 20.71M | 20.55M | 20.39M | 20.18M | 20.19M | 20.17M | 20.09M |
Shares Outstanding (Diluted) | 21.32M | 21.36M | 21.24M | 21.19M | 21.18M | 21.17M | 21.09M | 21.06M | 21.05M | 21.04M | 20.82M | 20.6M | 20.71M | 20.55M | 20.39M | 20.22M | 20.2M | 20.17M | 20.09M |
EPS (Basic) | -0.85 | -1.06 | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 | -1.33 | -1.86 | -1.79 | -1.39 | -1.28 | -1.53 | -1.62 | -1.48 | -1.22 | -1.19 | -1.09 | -0.41 |
EPS (Diluted) | -0.85 | -1.06 | -1.05 | -1.36 | -1.07 | -1.47 | -1.58 | -1.33 | -1.86 | -1.79 | -1.39 | -1.28 | -1.53 | -1.62 | -1.48 | -1.22 | -1.19 | -1.09 | -0.41 |
EBITDA | -16.61M | -21.03M | -19.86M | -26.13M | -20.1M | -28.34M | -29.95M | -25.7M | -32.2M | -37.07M | -28.51M | -26.39M | -31.43M | -33.02M | -29.63M | -32.92M | -33.02M | -28.87M | -11.43M |
EBIT | -16.61M | -22.23M | -20.74M | -26.61M | -20.7M | -28.96M | -30.59M | -26.37M | -32.85M | -37.61M | -29.02M | -27.05M | -32.15M | -33.85M | -30.41M | -33.73M | -33.85M | -29.7M | -12.3M |
Depreciation & Amortization | -2.09M | 1.2M | 889K | 479K | 594K | 621K | 642K | 669K | 651K | 540K | 511K | 655K | 716K | 822K | 780K | 806K | 823K | 834K | 871K |